Northrop Grumman Corporation

(New York Stock Exchange)
Back to all articles
Bullish +75

Northrop Grumman (NOC) Dips 2% Despite Q1 Beat β€” Analysts Project 29% Rally Ahead

AI-generated analysis

πŸ“‰ Northrop Grumman (NOC) shares dipped approximately 2% following the release of first-quarter results on April 21.

πŸ’° The company beat Wall Street estimates with adjusted EPS of $6.14 versus a forecast of $6.03.

πŸ“¦ Total revenue reached $9.88 billion, representing a 4.4% year-over-year increase against projections of $9.75 billion.

✈️ Revenue in the Aeronautics division surged 17%, driven by the B-21 Raider entering low-rate initial production.

πŸ›‘οΈ The U.S. Air Force has approved a 25% expansion in annual B-21 manufacturing capacity following the results.

βš–οΈ Company leadership is planning to invest $2.5 billion into B-21 production facilities by 2029 for infrastructure scaling.

πŸ—οΈ Northrop Grumman maintains a robust order backlog of approximately $96 billion, covering two to three years of revenue.

πŸ’Έ The defense contractor adjusted its full-year 2026 EPS guidance upward to between $27.40 and $27.90.

πŸ“‰ Financial analysts are projecting a potential price rally of roughly 29% toward an average target of $743.33.

🀝 Vanguard Group increased its stake in Northrop Grumman by 1.5% to about 9.63% of outstanding shares in Q4.

πŸ“Š The company declared a quarterly dividend of $2.31 per share, which yields 1.6% on an annualized basis.

πŸ•―οΈ Insider activity showed CAO Michael Hardesty divesting 147 shares at roughly $733 each earlier this year.

πŸ”Ή Analyst consensus remains Moderate Buy with no current Sell ratings among major institutional investors.

⚠️ Some analysts lowered price targets despite maintaining Buy or Outperform ratings due to revised guidance concerns.

πŸ“‰ The stock is currently trading below its 50-day and 200-day moving averages according to recent data.

🧩 Segment margins in Aeronautics rebounded to 9.3% as the company avoided loss charges affecting early 2025.

πŸš€ The Defense Systems segment posted 5% sales growth, while Mission Systems saw a 20% jump in operating income.

Bullish Signals
  • Northrop Grumman surpassed analyst expectations with Q1 adjusted EPS of $6.14 versus the anticipated $6.03.
  • Total revenue grew 4.4% year-over-year to $9.88 billion, exceeding Wall Street projections of $9.75 billion.
  • The Aeronautics division saw a robust 17% revenue surge driven by the B-21 Raider entering low-rate initial production.
  • The U.S. Air Force approved a 25% expansion in annual B-21 manufacturing capacity, confirming sustained demand for the stealth bomber.
  • A massive $96 billion order backlog provides approximately two to three years of secured future revenue.
  • Management plans to invest $2.5 billion in B-21 production facilities by 2029 to scale capacity for anticipated demand.
  • The Defense Systems segment achieved 5% sales growth, and Mission Systems operating income jumped 20% due to beneficial contract modifications.
  • Analyst consensus maintains a Moderate Buy rating with an average price target of $743.33, suggesting approximately 29% upside potential.
  • Vanguard Group increased its holdings by 1.5% in Q4, elevating ownership to approximately 9.63% of outstanding shares.
  • Multiple major institutions including Royal Bank of Canada, Deutsche Bank, UBS, and Citigroup maintain Buy or Outperform recommendations.
Risk Factors
  • The stock closed down 2% despite beating earnings per share expectations ($6.14 vs $6.03) and revenue targets ($9.88 billion), indicating investors are concerned about future execution rather than current performance.
  • Shares are trading below both the 50-day moving average of $699.43 and the 200-day average of $638.36, suggesting lingering selling pressure despite positive earnings guidance.
  • Capital expenditure guidance for 2026 was revised upward by $200 million, which may signal increased spending pressures that could impact future profit margins if not managed effectively.
  • Jefferies downgraded its position from Outperform to Hold and lowered its price target, while UBS, Citigroup also reduced their targets despite maintaining Buy ratings, reflecting some divergence in analyst sentiment.
  • Insider selling activity remains a concern, with CAO Michael Hardesty divesting 147 shares at $732.98 each on February 19, potentially indicating internal caution about valuations.
  • A quarterly dividend of $9.24 annually yields only 1.6%, which may be unattractive compared to other defense stocks or broader market opportunities in high-growth sectors.
Full Analysis
Northrop Grumman (NOC) shares declined approximately 2% following the release of its first-quarter earnings on April 21, despite delivering results that exceeded Wall Street expectations. The company reported adjusted earnings per share of $6.14 against an anticipated $6.03, and total revenue reached $9.88 billion, representing a 4.4% year-over-year increase versus the projected $9.75 billion. While the defense contractor met conventional financial metrics successfully, market reaction appeared sensitive to specific segment adjustments and guidance revisions. The Aeronautics division emerged as a significant growth driver with a 17% revenue surge, primarily fueled by the B-21 Raider stealth bomber transitioning into its low-rate initial production phase. This program received further momentum after the U.S. Air Force approved a 25% expansion in annual manufacturing capacity for the aircraft. To support this scaling, Northrop Grumman plans to invest $2.5 billion in B-21 production facilities by 2029 and has expanded its internal capital deployment over the last two years with more than 20 new manufacturing facilities. Additionally, the company maintains a robust order backlog of $96 billion, covering approximately two to three years of secured future revenue. Analyst sentiment remains constructive despite the short-term stock dip. The Street consensus is Moderate Buy, supported by ten Buy recommendations and five Hold ratings, with no analyst maintaining a Sell rating. Major banks such as Royal Bank of Canada, Deutsche Bank, UBS, and Citigroup maintain Buy stances, though some adjusted their price targets; for instance, Royal Bank of Canada raised its objective to $750, while JPMorgan Chase lowered it to $742. The average price target across analyst coverage is set at $743.33, suggesting approximately 29% potential upside from current levels. Vanguard Group increased its holdings by 1.5% in the fourth quarter to roughly 9.63% of outstanding shares. Northrop Grumman maintained its full-year 2026 EPS guidance between $27.40 and $27.90, with shares currently trading at approximately 21 times the 2026 consensus EPS estimate. The company also declared a quarterly dividend of $2.31 per share, yielding 1.6% on an annualized basis of $9.24.